Scotland v England deal on prescribed drugs

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39030.729954.3A (Published 16 November 2006) Cite this as: BMJ 2006;333:1073

Scottish Medicines Consortium responds

  1. David J Webb (d.j.webb@ed.ac.uk),
  2. Kenneth R Paterson, vice chairman,
  3. Angela Timoney, vice chairman,
  4. Andrew Walker, health economist
  1. 1Scottish Medicines Consortium, Delta House, Glasgow G1 2NP

We were disappointed to read the recent news article by Watts.1 On what seems to be no more evidence than an article in the Daily Mail he argues that application of the Barnett formula allows Scotland, through higher per capita funding, to be more free and easy in its approval of new medicines. A good story—the only problem is that he is completely wrong in his analysis.

The National Institute for Health and Clinical Excellence …

View Full Text

Log in

Log in through your institution


* For online subscription